319 related articles for article (PubMed ID: 19559686)
1. Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke.
Jackman KA; Miller AA; Drummond GR; Sobey CG
Brain Res; 2009 Aug; 1286():215-20. PubMed ID: 19559686
[TBL] [Abstract][Full Text] [Related]
2. NADPH-oxidase activity is elevated in penumbral and non-ischemic cerebral arteries following stroke.
Miller AA; Dusting GJ; Roulston CL; Sobey CG
Brain Res; 2006 Sep; 1111(1):111-6. PubMed ID: 16879806
[TBL] [Abstract][Full Text] [Related]
3. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.
Iwai M; Liu HW; Chen R; Ide A; Okamoto S; Hata R; Sakanaka M; Shiuchi T; Horiuchi M
Circulation; 2004 Aug; 110(7):843-8. PubMed ID: 15289370
[TBL] [Abstract][Full Text] [Related]
4. Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice.
Mogi M; Iwai M; Chen R; Iwanami J; Ide A; Tsukuda K; Yoshii T; Horiuchi M
Am J Hypertens; 2006 Nov; 19(11):1144-9. PubMed ID: 17070425
[TBL] [Abstract][Full Text] [Related]
5. NADPH oxidase Nox1 contributes to ischemic injury in experimental stroke in mice.
Kahles T; Kohnen A; Heumueller S; Rappert A; Bechmann I; Liebner S; Wittko IM; Neumann-Haefelin T; Steinmetz H; Schroeder K; Brandes RP
Neurobiol Dis; 2010 Oct; 40(1):185-92. PubMed ID: 20580928
[TBL] [Abstract][Full Text] [Related]
6. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice.
Matsuno K; Yamada H; Iwata K; Jin D; Katsuyama M; Matsuki M; Takai S; Yamanishi K; Miyazaki M; Matsubara H; Yabe-Nishimura C
Circulation; 2005 Oct; 112(17):2677-85. PubMed ID: 16246966
[TBL] [Abstract][Full Text] [Related]
7. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms.
Nishimura M; Izumiya Y; Higuchi A; Shibata R; Qiu J; Kudo C; Shin HK; Moskowitz MA; Ouchi N
Circulation; 2008 Jan; 117(2):216-23. PubMed ID: 18158361
[TBL] [Abstract][Full Text] [Related]
9. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model.
Hughes PM; Allegrini PR; Rudin M; Perry VH; Mir AK; Wiessner C
J Cereb Blood Flow Metab; 2002 Mar; 22(3):308-17. PubMed ID: 11891436
[TBL] [Abstract][Full Text] [Related]
10. Decreased blood pressure in NOX1-deficient mice.
Gavazzi G; Banfi B; Deffert C; Fiette L; Schappi M; Herrmann F; Krause KH
FEBS Lett; 2006 Jan; 580(2):497-504. PubMed ID: 16386251
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through nox-2-derived radicals.
Girouard H; Park L; Anrather J; Zhou P; Iadecola C
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):826-32. PubMed ID: 16439707
[TBL] [Abstract][Full Text] [Related]
12. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice.
Dikalova A; Clempus R; Lassègue B; Cheng G; McCoy J; Dikalov S; San Martin A; Lyle A; Weber DS; Weiss D; Taylor WR; Schmidt HH; Owens GK; Lambeth JD; Griendling KK
Circulation; 2005 Oct; 112(17):2668-76. PubMed ID: 16230485
[TBL] [Abstract][Full Text] [Related]
13. Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain.
Chrissobolis S; Banfi B; Sobey CG; Faraci FM
J Appl Physiol (1985); 2012 Jul; 113(2):184-91. PubMed ID: 22628375
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-deficient mice.
Iwai M; Inaba S; Tomono Y; Kanno H; Iwanami J; Mogi M; Horiuchi M
Hypertens Res; 2008 Jan; 31(1):161-8. PubMed ID: 18360031
[TBL] [Abstract][Full Text] [Related]
15. Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II.
Matsui R; Xu S; Maitland KA; Hayes A; Leopold JA; Handy DE; Loscalzo J; Cohen RA
Circulation; 2005 Jul; 112(2):257-63. PubMed ID: 15998684
[TBL] [Abstract][Full Text] [Related]
16. Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats.
Zhao H; Sapolsky RM; Steinberg GK
J Cereb Blood Flow Metab; 2006 Sep; 26(9):1114-21. PubMed ID: 16736038
[TBL] [Abstract][Full Text] [Related]
17. Increased susceptibility to ischemic brain injury in cyclooxygenase-1-deficient mice.
Iadecola C; Sugimoto K; Niwa K; Kazama K; Ross ME
J Cereb Blood Flow Metab; 2001 Dec; 21(12):1436-41. PubMed ID: 11740205
[TBL] [Abstract][Full Text] [Related]
18. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries.
Miller AA; Drummond GR; Schmidt HH; Sobey CG
Circ Res; 2005 Nov; 97(10):1055-62. PubMed ID: 16210546
[TBL] [Abstract][Full Text] [Related]
19. Melatonin reduces infarction volume in a photothrombotic stroke model in the wild-type but not cyclooxygenase-1-gene knockout mice.
Zou LY; Cheung RT; Liu S; Li G; Huang L
J Pineal Res; 2006 Sep; 41(2):150-6. PubMed ID: 16879321
[TBL] [Abstract][Full Text] [Related]
20. Larger anastomoses in angiotensinogen-knockout mice attenuate early metabolic disturbances after middle cerebral artery occlusion.
Maeda K; Hata R; Bader M; Walther T; Hossmann KA
J Cereb Blood Flow Metab; 1999 Oct; 19(10):1092-8. PubMed ID: 10532633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
